英文名稱(chēng) | Tadocizumab |
---|---|
中文名稱(chēng) | 他度組單抗 |
CAS號(hào) | 339086-80-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥5200.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥22100.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥38000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥152000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥275000.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Tadocizumab |
---|---|
中文名稱(chēng) | 他度組單抗 |
CAS號(hào) | 339086-80-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.